Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
614 Ergebnisse
| JY2BK8 | Vertex Pharmaceuticals Inc./KO/Put [endlos]/JPMD | - | - | put | Vertex Pharmaceuticals Inc. | 843,883 | 759,400 | 1,271 | 60,540 % | - | JP Morgan | ||
| JY2BK9 | Vertex Pharmaceuticals Inc./KO/Put [endlos]/JPMD | - | - | put | Vertex Pharmaceuticals Inc. | 866,091 | 779,400 | 1,198 | 64,768 % | - | JP Morgan | ||
| JY2BXF | Vertex Pharmaceuticals Inc./Faktor/Short [9]/JPMD | - | - | put | Vertex Pharmaceuticals Inc. | 525,632 | 496,400 | - | 10,984 % | - | JP Morgan | ||
| JY2W1J | Vertex Pharmaceuticals Inc./KO/Call [endlos]/JPMD | - | - | call | Vertex Pharmaceuticals Inc. | 441,789 | 441,789 | 12,616 | 6,639 % | - | JP Morgan | ||
| JY3FPZ | Vertex Pharmaceuticals Inc./Faktor/Long [8]/JPMD | - | - | call | Vertex Pharmaceuticals Inc. | 414,063 | 439,950 | - | 12,573 % | - | JP Morgan | ||
| JY3FQ0 | Vertex Pharmaceuticals Inc./Faktor/Long [11]/JPMD | - | - | call | Vertex Pharmaceuticals Inc. | 430,194 | 448,440 | - | 9,167 % | - | JP Morgan | ||
| JY3FQ2 | Vertex Pharmaceuticals Inc./Faktor/Long [10]/JPMD | - | - | call | Vertex Pharmaceuticals Inc. | 425,892 | 447,190 | - | 10,075 % | - | JP Morgan | ||
| JY3FQ3 | Vertex Pharmaceuticals Inc./Faktor/Long [6]/JPMD | - | - | call | Vertex Pharmaceuticals Inc. | 394,347 | 427,200 | - | 16,736 % | - | JP Morgan | ||
| JY3FQ4 | Vertex Pharmaceuticals Inc./Faktor/Long [14]/JPMD | - | - | call | Vertex Pharmaceuticals Inc. | 439,412 | 452,120 | - | 7,221 % | - | JP Morgan | ||
| JY3FQ5 | Vertex Pharmaceuticals Inc./Faktor/Long [15]/JPMD | - | - | call | Vertex Pharmaceuticals Inc. | 441,665 | 453,460 | - | 6,745 % | - | JP Morgan | ||
| JY3FQ6 | Vertex Pharmaceuticals Inc./Faktor/Long [12]/JPMD | - | - | call | Vertex Pharmaceuticals Inc. | 433,779 | 450,480 | - | 8,410 % | - | JP Morgan | ||
| JY3FQ7 | Vertex Pharmaceuticals Inc./Faktor/Long [7]/JPMD | - | - | call | Vertex Pharmaceuticals Inc. | 405,613 | 434,580 | - | 14,357 % | - | JP Morgan | ||
| JY3FQ8 | Vertex Pharmaceuticals Inc./Faktor/Long [9]/JPMD | - | - | call | Vertex Pharmaceuticals Inc. | 420,635 | 444,030 | - | 11,186 % | - | JP Morgan | ||
| JY3FQA | Vertex Pharmaceuticals Inc./Faktor/Long [13]/JPMD | - | - | call | Vertex Pharmaceuticals Inc. | 436,812 | 450,750 | - | 7,770 % | - | JP Morgan | ||
| LX43LM | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 312,667 | 312,667 | 3,645 | 24,504 % | - | Lang & Schwarz | ||
| LX43LN | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 335,001 | 335,001 | 4,526 | 19,111 % | - | Lang & Schwarz | ||
| LX5H9D | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 329,914 | 329,914 | 4,290 | 20,339 % | - | Lang & Schwarz | ||
| LX6F8P | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 296,554 | 296,554 | 3,193 | 28,395 % | - | Lang & Schwarz | ||
| LX6HB0 | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 301,613 | 301,613 | 3,388 | 27,173 % | - | Lang & Schwarz | ||
| LX6HBY | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 258,876 | 258,876 | 2,546 | 37,492 % | - | Lang & Schwarz | ||
| LX6HBZ | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 280,245 | 280,245 | 2,860 | 32,333 % | - | Lang & Schwarz | ||
| LX6XGC | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 343,535 | 343,535 | 4,962 | 17,051 % | - | Lang & Schwarz | ||
| LX6XGD | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 354,105 | 354,105 | 5,642 | 14,498 % | - | Lang & Schwarz | ||
| LX721L | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 247,553 | 247,553 | 2,327 | 40,226 % | - | Lang & Schwarz | ||
| LX74VN | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 269,204 | 269,204 | 2,640 | 34,998 % | - | Lang & Schwarz | ||
| LX82UJ | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 364,175 | 364,175 | 6,669 | 12,067 % | - | Lang & Schwarz | ||
| LX9GSD | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 374,178 | 374,178 | 7,771 | 9,652 % | - | Lang & Schwarz | ||
| LX9JP6 | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 392,096 | 392,096 | 11,671 | 5,325 % | - | Lang & Schwarz | ||
| LX9KA1 | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 401,842 | 401,842 | 15,840 | 2,972 % | - | Lang & Schwarz | ||
| LX9KPQ | Vertex Pharmaceuticals Inc./KO/Call [endlos]/LuS | - | - | call | Vertex Pharmaceuticals Inc. | 411,809 | 411,809 | 24,226 | 0,565 % | - | Lang & Schwarz | ||
| MB7K7M |  | Vertex Pharmaceuticals Inc./Faktor/Long [3]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 315,105 | 315,105 | 3,011 | 33,394 % | - | Morgan Stanley | |
| MC1UYN | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 189,478 | 189,478 | 1,661 | 59,957 % | - | Morgan Stanley | |
| MC4JT8 | | Vertex Pharmaceuticals Inc./Faktor/Long [4]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 354,483 | 354,483 | 4,024 | 25,071 % | - | Morgan Stanley | |
| MD33DU | | Vertex Pharmaceuticals Inc./Faktor/Short [4]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 590,723 | 590,723 | - | 24,865 % | - | Morgan Stanley | |
| MD3AM6 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 336,627 | 336,627 | 3,492 | 28,861 % | - | Morgan Stanley | |
| MD5HWD | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 332,453 | 375,420 | 3,379 | 20,645 % | - | Morgan Stanley | |
| MD7Y8L | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 356,354 | 356,354 | 4,083 | 24,692 % | - | Morgan Stanley | |
| MG27HQ | | Vertex Pharmaceuticals Inc./Faktor/Long [2]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 236,338 | 236,338 | 2,015 | 50,044 % | - | Morgan Stanley | |
| MG2KV8 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 321,689 | 321,689 | 3,099 | 32,018 % | - | Morgan Stanley | |
| MG8E95 | | Vertex Pharmaceuticals Inc./KO/Put [endlos]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 596,560 | 596,560 | 3,726 | 26,102 % | - | Morgan Stanley | |
| MJ42ER | | Vertex Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 378,141 | 378,141 | 5,027 | 20,070 % | - | Morgan Stanley | |
| MJ6HVZ | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 305,370 | 344,840 | 2,806 | 27,109 % | - | Morgan Stanley | |
| MK6YBX | | Vertex Pharmaceuticals Inc./Faktor/Long [6]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 393,897 | 393,897 | 6,041 | 16,740 % | - | Morgan Stanley | |
| MK944K | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 328,779 | 328,779 | 3,256 | 30,504 % | - | Morgan Stanley | |
| MM0X2T | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 370,059 | 370,059 | 4,587 | 21,778 % | - | Morgan Stanley | |
| MM1KV0 | | Vertex Pharmaceuticals Inc./Faktor/Short [6]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 551,318 | 551,318 | 5,755 | 16,536 % | - | Morgan Stanley | |
| MM20ED | | Vertex Pharmaceuticals Inc./Faktor/Long [4]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 354,507 | 354,507 | 4,075 | 25,066 % | - | Morgan Stanley | |
| MM20EE | | Vertex Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 378,141 | 378,141 | 5,120 | 20,070 % | - | Morgan Stanley | |
| MM20EF | | Vertex Pharmaceuticals Inc./Faktor/Long [6]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 393,897 | 393,897 | 6,112 | 16,740 % | - | Morgan Stanley | |
| MM20EG | | Vertex Pharmaceuticals Inc./Faktor/Long [8]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 413,592 | 413,592 | - | 12,576 % | - | Morgan Stanley |